好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Efficacy of 4mg Sumatriptan Subcutaneous Injection for the Treatment of Moderate to Severe Migraine Attacks: A Double-Blind, Placebo-Controlled Trial
Headache and Pain
(-)
002
Authors/Disclosures
Jeanette K. Wendt, MD No disclosure on file
Aya M. Haggiagi, MD (Columbia University Medical Center) No disclosure on file
No disclosure on file
Edward Avila, DO, FAAN (Memorial Sloan-Kettering Cancer Center) No disclosure on file
No disclosure on file
Richard P. Singer, MD, FAAN (The Neurology Institite) No disclosure on file
No disclosure on file
No disclosure on file
Christopher J. Webster, BS No disclosure on file
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
No disclosure on file
Miguel Angel Hernandez Perez (Hospital Nuestra Senora de Candelaria) Miguel Angel Hernandez Perez has nothing to disclose.
Susan C. Byrd, RPh (GlaxoSmithKline) No disclosure on file